In the last trading session, 7.57 million shares of the CVS Health Corp (NYSE:CVS) were traded, and its beta was 0.56. Most recently the company’s share price was $67.71, and it changed around $0.25 or 0.37% from the last close, which brings the market valuation of the company to $85.65B. CVS currently trades at a discount to its 52-week high of $72.51, offering almost -7.09% off that amount. The share price’s 52-week low was $43.56, which indicates that the current value has risen by an impressive 35.67% since then.
CVS Health Corp stock received a consensus recommendation rating of Buy, based on a mean score of 1.69. If we narrow it down even further, the data shows that 0 out of 28 analysts rate the stock as a Sell; another 8 rate it as Overweight. Among the rest, 7 recommended CVS as a Hold, whereas 13 deemed it a Buy, and 0 rated it as Underweight. CVS Health Corp is expected to report earnings per share of 1.45 for the current quarter.
CVS Health Corp (NYSE:CVS) trade information
Instantly CVS has showed a green trend with a performance of 0.37% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 68.31 on recent trading dayincreased the stock’s daily price by 0.88%. The company’s shares are currently up 50.84% year-to-date, but still up 6.03% over the last five days. On the other hand, CVS Health Corp (NYSE:CVS) is 11.97% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $78, which translates to bulls needing to increase their stock price by 13.19% from its current value. Analyst projections state that CVS is forecast to be at a low of $77 and a high of $79.
CVS Health Corp (CVS) estimates and forecasts
The year-over-year growth rate is expected to be 3.94%, up from the previous year.
Consensus estimates provided by 18 financial analysts predict the company will bring in an average of 94.87B in revenue for the current quarter. 18 analysts expect CVS Health Corp to make 97.85B in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 91.23B and 95.43B respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 3.98%. Forecasts for the next quarter put sales growth at 2.53%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -6.37%. CVS Health Corp earnings are expected to increase by 13.02% in 2025, but the outlook is positive 13.70% per year for the next five years.
CVS Dividends
CVS Health Corp’s next quarterly earnings report is expected to be released in July. The annual dividend yield of the stock is 3.93 percent and its annual dividend per share was 2.66. It is important to note, however, that the 3.93% dividend yield ratio should be regarded as a guide only, as many other factors should be taken into consideration before making any investment decision.
BLACKROCK INC., with 7.9738% or 100.15 million shares worth $5.91 billion as of 2024-06-30, holds the second largest percentage of outstanding shares.
